Document is current
Any future updates will be listed below
-
Authors
Segev, Aviv http://orcid.org/0000-0002-9550-3895
Govind, Risha http://orcid.org/0000-0001-9925-7866
Oloyede, Ebenezer http://orcid.org/0000-0003-1352-4017
Morrin, Hamilton http://orcid.org/0000-0002-7801-0212
Jewell, Amelia http://orcid.org/0000-0002-0887-2159
Jones, Rowena http://orcid.org/0000-0002-3426-1394
Mangiaterra, Laura
Bonora, Stefano
Iqbal, Ehtesham http://orcid.org/0000-0001-9477-9745
Stewart, Robert http://orcid.org/0000-0002-4435-6397
Broadbent, Matthew
MacCabe, James H. http://orcid.org/0000-0002-6754-1018
-
Funding
Funding for this research was provided by:
Medical Research Council (MR/W014386, MR-VO49879/1)
National Institute for Health and Care Research (NIHR131157, NIHR150308, NIHR131175)
- License Information
-
More Information
Article History
Received: 18 May 2024
Accepted: 14 August 2024
First Online: 27 August 2024
Declarations
:
: The CRIS data, including the linked data used in this manuscript, has received research ethics approval for secondary analyses (Oxford REC C, reference 18/SC/0372). The CRIS Oversight Committee ensures that research conducted using health records is ethical and legal, and service users can opt-out of their CRIS data being used for research [].
: Not relevant to the current manuscript.
: RS declares research support received within the last 3 years from Janssen, GSK and Takeda. JHM has received investigator-initiated research funding from H Lundbeck. He has received research funding for clinical trials from H Lundbeck and Karuna Therapeutics. He has participated in advisory boards for H Lundbeck, LB Pharma, Newron Pharmaceuticals and Teva UK Ltd.
